Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results ...

That distinction is the most important conversation business leaders aren’t having. Nature optimizes for survival. Most ...

On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) by end of this month - - GLIX1 is positioned to potentially address unmet ...

Inequities in science affect who can publish, access funding, and drive innovation. Hear from global experts as they discuss ...

New research links gum disease to the development of breast cancer.

Researchers have created the first living synthetic bacterium made from non-living parts by killing a bacterial cell and then ...

We join designer David Durand for a weekend in the alps to find out how this budget brand became so fashionable ...

Skin wound healing shows a unique cellular function mechanism involving the interaction of several cells, growth factors, and ...

The name might sound like a Nordic god, but it is actually the molecular machinery that allows many different species to eat ...

Arthropod-borne viruses (arboviruses), such as dengue and Zika viruses, transmit widely across the globe, posing threats to ...

Emerging antiviral defense systems are expanding the conceptual and practical boundaries of genome editing. Across bacteria, archaea, and eukaryotes, hosts ...